FDA Plays

[Do DD]

Not me: I'm cautious if ACUR will attain the coveted “deter common methods of misuse and abuse” label. If they don't, Acurox is dead in the water, since it's basically a generic drug with components added to deter abuse.
Also: how to rate abuse deterrence with actual abusers in a clinical setting?
It could still be that an actual abuser will be vomiting all over the place after taking Acurox but if the high would be worth it in the eyes of the abuser they would probably still take it.

Clinical trials are usually performed with sane patients...

For those who are curious: next tuesday, the 20th, the FDA site will have the presentation materials of Acura and the FDA available so an opinion can be formed on the possible outcome of the hearing. Be aware that the FDA will play the role of devil's advocate here...